GlassScriptPhysician profile
Franklin Farid
NPI 1225532856
$13,208.20
in general payments reported to CMS, 2019-2025
11 companies · $2,229 in 2025
The $2,229 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2022: $159 · 2023: $4,171 · 2024: $6,502 · 2025: $2,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,500 · Food and Beverage: $4,624 · Education: $1,564 · Travel and Lodging: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,500.00 |
| Food and Beverage | $4,624.00 |
| Education | $1,564.00 |
| Travel and Lodging | $1,214.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,217.53 | 2023-2025 | Endurant Iis |
| Bolton Medical INC | $2,162.10 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $1,000.61 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Endoprosthesis |
| Terumo Medical Corporation | $650.59 | 2024 | Azur Cx Detachable, Tr Band, R2p Misago |
| Angiodynamics, INC. | $252.78 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Silk Road Medical, INC. | $216.62 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Shockwave Medical, INC | $207.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $147.69 | 2024 | Mamba |
| Allergan, INC. | $146.34 | 2019 | |
| Endologix LLC | $136.28 | 2025 | Alto Abdominal Stent Graft System |
| Amgen INC. | $69.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Farid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.